Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Statins and cancer development.

Duncan RE, El-Sohemy A, Archer MC.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1897-8. Review.

2.
3.
5.

Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.

Verhulst A, D'Haese PC, De Broe ME.

J Am Soc Nephrol. 2004 Sep;15(9):2249-57.

7.

Short-term effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor on cholesterol and bile acid synthesis in humans.

Yoshida T, Honda A, Shoda J, Abei M, Matsuzaki Y, Tanaka N, Miyazaki H, Osuga T.

Lipids. 1997 Aug;32(8):873-8.

PMID:
9270980
8.
9.

Effects of pravastatin sodium on mevalonate metabolism in common marmosets.

Miyazaki A, Koieyama T, Shimada Y, Kikuchi T, Nezu H, Ito K, Kasanuki N, Koga T.

J Biochem. 2002 Sep;132(3):395-400.

10.

The effects of pravastatin, an HMG-CoA reductase inhibitor, on cell viability and DNA production of rat hepatocytes.

Satoh T, Isobe H, Ayukawa K, Sakai H, Nawata H.

Life Sci. 1996;59(14):1103-8.

PMID:
8831797
11.

Hypothesis: the antitumor activities of statins may be mediated by IL-18.

Takahashi HK, Weitz-Schmidt G, Iwagaki H, Yoshino T, Tanaka N, Nishibori M.

J Leukoc Biol. 2006 Aug;80(2):215-6.

PMID:
16735695
12.
13.

Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).

Kawata S, Nagase T, Yamasaki E, Ishiguro H, Matsuzawa Y.

Br J Cancer. 1994 Jun;69(6):1015-20.

14.

Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.

Tanaka T, Porter CM, Horvath-Arcidiacono JA, Bloom ET.

Int Immunol. 2007 Feb;19(2):163-73.

PMID:
17182966
15.

The 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neurons.

Pooler AM, Xi SC, Wurtman RJ.

J Neurochem. 2006 May;97(3):716-23. Erratum in: J Neurochem. 2006 Aug;98(3):992.

16.

Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer.

Elson CE, Peffley DM, Hentosh P, Mo H.

Proc Soc Exp Biol Med. 1999 Sep;221(4):294-311. Review.

PMID:
10460692
17.

Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.

Hedl M, Rodwell VW.

Protein Sci. 2004 Jun;13(6):1693-7.

18.

Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene.

Ohashi K, Osuga J, Tozawa R, Kitamine T, Yagyu H, Sekiya M, Tomita S, Okazaki H, Tamura Y, Yahagi N, Iizuka Y, Harada K, Gotoda T, Shimano H, Yamada N, Ishibashi S.

J Biol Chem. 2003 Oct 31;278(44):42936-41.

19.

Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.

McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H.

Exp Biol Med (Maywood). 2007 Apr;232(4):523-31.

PMID:
17392488
20.

Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells.

Sidaway JE, Davidson RG, McTaggart F, Orton TC, Scott RC, Smith GJ, Brunskill NJ.

J Am Soc Nephrol. 2004 Sep;15(9):2258-65.

Supplemental Content

Support Center